References
- Zielasek J., Jackson R A, Eisenbarth G S. The potentially simple mathematics of type 1 diabetes. Clin Immunol Immunopathol 1989; 52: 347–365
- Tarn AAl C., Sakkaf L, Gale E AM. Autoimmunity in pie-diabetes. Baillière's Clinical Immunology and Allergy 1987; 1: 165–186
- Alviggi L, Hoskins P J, Pyke D, Johnston A. C, Tee D EH, Leslie R DG. Pathogenesis of insulin-dependent diabetes: a role for activated T lymphocytes. Lancet 1984; ii: 4–6
- Roncarolo M G, Zoppo Bacchetta M. R, Gabiano C, Sacchetti C, Cerutti Tovo F. PA. lnterleukin-2 production and interlcuk-in-2 receptor expression in children with newly diagtiosed diabetes. Clinical Immunology and Immunopathology 1988; 49: 53–62
- De Berardinis P, Londei M, Kahan Balsano M. F, Konliainen S, Gale E AM, Bottazzo G F, Fclmann M. The majority of activated T cells in the blood of insulin-dependent diabetes mel-litus (IDDM) patients are CD4+. Clin Exp Immunol 1988; 73: 255–259
- Nicoletti F, Caruso M, Di Mauro M, Stracuzzi S, Mancuso M, Scuderi G, Leonardi C, Pagano M, Lunetta M. CD3+CD25+ cells, CD3+CD4+/CD3+CD8+ ratio, HLA alloantigen association and ICA in type 1 (insulin-dependent) diabetes. Med Sci Res 1990; 18: 679–681
- Herold K C, Huen A, Gould L, Traisman H, Rubenstein A H. Alterations in lymphocyte subpopulations in type 1 (insulin-dependent) diabetes mellitus: exploration of possible mechanisms and relationship to autoimmune phenomena. Diabet-ologia 1984; 27: 102–105
- Nicoletti F, Meroni P L, Barcellini W, Steinsvag P O, Di Mauro M, Lunetta M, Pagano M, Consoli U, Zanussi C. Enhanced percentage of CD5+ B lymphocytes in newly diagnosed IDDM patients. Immunology Letters 1990; 23: 211–215
- Lee K U, Amano K, Yoon J-W. Evidence for initial involvement of macrophages in development of insulitis in NOD mice. Diabetes 1988; 37: 989–991
- Walker R, Bone A J, Cooke A, Baird J D. Distinct macrophage subpopulations in pancreas of prediabetic BB/E rats. Possible role for macrophages in pathogenesis of IDDM. Diabetes 1988; 37: 1301–1304
- Kiesel U, Oschilewski M, Kantwerk G, Maruta M, Hanenberg H, Treichel U, Kolb-Bachofen V, Harting H P, Kob H. Essential role of macrophages in the developments of type 1 diabetes in BB rats. Transplant Proc 1986; 18: 1525–1527
- Oscchilewski M, Kiesel U, Kolb H. Administration of silica prevents diabetes in BB-rats. Diabetes 1985; 34: 197–199
- Yanagawa T, Maruyama T, Takei I, Asaba Y, Tatahashi T, Kataoka K, Minishima S, Shimizu N, Tadakuma T, Ishii T. Prevention of diabetes in NOD mice by silica treatment. Immunology of Diabetes, 9th Int. Workshop, MelbourneAustralia, November, 27–291988
- Kakumu S, Kentaro Y, Yasuhiko T, Wakita T, Motohiro A. Production of tumor necrosis factor, interleukin 1 and interferon gamma by peripheral blood mononuclear cells from patients with primary biliary cirrhosis. Clinical Immunology and Immunopathology 1990; 56: 54–65
- Hermann F, Cannistra S A, Levine H, Griffin J D. Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells. J Exp Med 1985; 162: 1111–1116
- Hermann F, Cannistra S A, Lindemann A, Biohm D, Rambaldi A, Mertelsmann H, Griffin J D. Functional consequence of monocyte IL-2 receptor expression. Induction of ILl-beta secretion by IFN gamma and IL-2. J Immunol 1989; 142: 139–143
- Janeway C A, Bottomly K, Babich J, Conrad P, Conzen S, Jones B, Kaye J, Katz M, McVay L, Murphy D B, Tite J. Quantitative variation in la antigen expression plays a central role in immune regulation. Immunol Today 1984; 5: 99–105
- Bendtzeu K. Immune Hormones (cytokines); Pathogenetic role in autoimmune, rheumatic and endoraine diseases. Autoimmunity 1989; 2: 177–189
- Pujol-Borrell R, Todd I, Doshi M, Bottazzo G F, Sutton R, Gray D, Adolf G, Feldmann M. HLA class II induction in human islet cells by interferon gamma plus tumour necrosis factor or lymphotoxin. Nature 1987; 326: 304–306
- Pukel C, Baquerizo H, Rabinovitch A. Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon gamma, tumor necrosis factor, lymphotoxin and interleukin I. Diabetes 1988; 37: 133–136